IceCure Medical Ltd. Insider Ownership | ICCM

Insider Holdings by Owner

1.27Mn Shares

Eyal Shamir431.28K34.0%

Meir Peleg194.82K15.4%

Ron Mayron176.46K13.9%

Shay Levav146.30K11.5%

Shad Good136.70K10.8%

Other insiders (2)182.69K14.4%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

31.17%

Shares Held by Insiders

660.50K

filed for Sep 2026

Shares Outstanding

2.12Mn

2,119,308 shares

Direct Holdings

660.50K

Indirect: 0

Net Open-Market Trades

0

no open-market trades in Sep 2026

Insiders Holding Shares

7

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Nov 4, 2026

Over the trailing 12 months, ICCM insiders made no open-market trades in the stock.

In transactions other than open-market trades, IceCure Medical insiders received 1.2Mn shares in stock awards over the past 12 months.
According to Business Quant data, insiders at IceCure Medical reported 1.27Mn shares in total in their latest Form 4 filings.
None of the 1.27Mn shares held by IceCure Medical insiders is held through trusts, partnerships or family members; all are direct holdings.
Business Quant counts 7 insiders with holdings in IceCure Medical stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
IceCure Medical's top three insider holders by shares held are Eyal Shamir (Chief Executive Officer, 431.28K shares), Meir Peleg (Chief Financial Officer, 194.82K shares) and Ron Mayron (Director, 176.46K shares).
Of the shares held by ICCM insiders, 34.01% belong to Eyal Shamir.
In the past year, 7 insiders of IceCure Medical submitted 7 Form 4 filings reporting trades, awards or other transactions.
This summary of IceCure Medical insider activity covers Form 4 filings through November 2, 2026.

Form 4 Holdings

Insiders Holding ICCM

Insiders 7

Shares held 1.27Mn

Of outstanding 59.84%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Eyal Shamir	Chief Executive Officer	431,281	431,281	34.0%	02 Nov, 2026
2	Meir Peleg	Chief Financial Officer	194,816	194,816	15.4%	17 Aug, 2026
3	Ron Mayron	Director	176,464	176,464	13.9%	02 Nov, 2026
4	Shay Levav	Chief Operating Officer	146,303	146,303	11.5%	17 Aug, 2026
5	Shad Good	Vp, Sales For North America	136,698	136,698	10.8%	17 Aug, 2026
6	Tlalit Bussi Tel-Tzure	Vp, Bd Global Marketing	106,518	106,518	8.4%	17 Aug, 2026
7	Merav Nir Dotan	Vp, Human Resources	76,168	76,168	6.0%	17 Aug, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

7 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
02 Nov, 2026	Ron Mayron	Director	Acquired A	166,577	$0.00	$0	176,464	Direct
02 Nov, 2026	Eyal Shamir	Chief Executive Officer	Acquired A	404,901	$0.00	$0	431,281	Direct
14 Aug, 2026	Shad Good	Vp, Sales For North America	Acquired A	131,483	$0.00	$0	136,698	Direct
14 Aug, 2026	Shay Levav	Chief Operating Officer	Acquired A	141,483	$0.00	$0	146,303	Direct
14 Aug, 2026	Meir Peleg	Chief Financial Officer	Acquired A	181,483	$0.00	$0	194,816	Direct
14 Aug, 2026	Tlalit Bussi Tel-Tzure	Vp, Bd Global Marketing	Acquired A	101,483	$0.00	$0	106,518	Direct
14 Aug, 2026	Merav Nir Dotan	Vp, Human Resources	Acquired A	73,890	$0.00	$0	76,168	Direct

IceCure Medical ICCM Insider Ownership